Tech companies gain favor of Congress in bid to relax regulations

A lobbying campaign by technology companies that will profit from selling digital health has been successful so far, reports Politico.

In the past few weeks, the FDA has promised not to regulate technologies that receive, transmit, store or display data from medical devices, while indicating that it will not regulate most low-risk mobile apps, according to the story.

Read more below:

Around the web

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.